Osaka, Japan

Hisao Kasuga

This inventor holds 2 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 2000-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hisao Kasuga. Retrieved from https://idiyas.com/inventor/hisao-kasuga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Location History:

  • Toyonaka, JP (2000)
  • Osaka, JP (2001)

Company Filing History:


Years Active: 2000-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hisao Kasuga: Innovator in Transgenic Animal Models

Introduction

Hisao Kasuga is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biomedical research through his innovative work in transgenic animal models. His inventions have the potential to advance our understanding of various diseases and aid in the development of therapeutic modalities.

Latest Patents

Hisao Kasuga holds 2 patents, with his latest inventions focusing on transgenic animals that serve as models for various diseases. One of his notable patents is for the 25-hydroxyvitamin D3 24-hydroylase transgenic rats. This transgenic animal can be utilized as a model for renal disease, bone disease, joint disease, pulmonary disease, hyperlipidemia, arteriosclerosis, cardiac disease, diabetes, obesity, digestive organ disease, infectious disease, allergic disease, endocrine disease, dementia, or cancer, along with their complications. This invention provides a nonhuman transgenic mammal that can help unravel the mechanisms of these diseases, explore therapeutic modalities, and screen candidate therapeutic drugs.

Another significant patent is for the monocyte chemoattractant protein and its receptor transgenic animal. This invention introduces an exogenous gene or a mutant gene of a monocyte chemoattractant protein and/or its receptor into a non-human animal. These transgenic animals can be used as pathological models for heart diseases, respiratory diseases, joint diseases, kidney diseases, arteriosclerosis, psoriasis, hyperlipidemia, allergic diseases, bone diseases, blood diseases, cerebrovascular disorders, traumatic cerebral disorders, infectious diseases, dementia, or chronic inflammatory diseases. This allows for the elucidation of the mechanisms of pathogenesis, determination of therapies, and screening for candidate compounds for therapeutic drug development.

Career Highlights

Hisao Kasuga is associated with Takeda Chemical Industries, Inc., where he continues to contribute to groundbreaking research in the field of transgenic models. His work has garnered attention for its potential impact on understanding complex diseases and developing new treatments.

Collaborations

He has collaborated with notable colleagues, including Masami Isaka and Takahito Kitayoshi, to further advance research in his field. Their combined expertise has led to significant advancements in the understanding of disease mechanisms.

Conclusion

Hisao Kasuga's innovative work in transgenic animal models

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…